Molly Scott

Dr. Scott is a Vice President at Oberland Capital. Previously, Dr. Scott was a Consultant at ClearView Healthcare Partners, where she supported strategic advising to biotechnology and pharmaceutical companies. Prior to ClearView, Dr. Scott completed a Ph.D. at Yale University. Her research leveraged genetics, cell biology, and computational imaging to characterize the molecular mechanisms underlying bacterial proliferation. Dr. Scott also holds a B.A. from Amherst College in Biology and Spanish.